Cytocom, Inc.
NASDAQ: CBLI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yakov Kogan
- Employees
- 18
- Headquarters
- Buffalo, United States
- IPO year
- 2006
- Market cap
- $226.4M
- Website
- http://www.cytocom.com
Loading CBLI…
Loading profile data…Frequently asked questions about CBLI
What does Cytocom, Inc. (CBLI) do?
Cleveland BioLabs, Inc. functions as a biopharmaceutical firm, specializing in the discovery and advancement of therapeutic drugs. Based in Buffalo, New York, the organization maintains a modest workforce of 15 full-time employees. Its primary objective involves pioneering methods to stimulate the body's immune defenses to tackle significant med...
Where does CBLI trade?
Cytocom, Inc. (CBLI) trades on the NASDAQ Capital Market.
What sector is CBLI in?
Cytocom, Inc. (CBLI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cytocom, Inc.?
Yakov Kogan is the chief executive officer of Cytocom, Inc. (CBLI).
Where is Cytocom, Inc. headquartered?
Cytocom, Inc. is headquartered in United States.
Does CBLI pay a dividend?
Cytocom, Inc. (CBLI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CBLI go public?
Cytocom, Inc. (CBLI) completed its initial public offering in 2006.